Article
Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Clinical lymphoma, myeloma & leukemia - 1 Mar 2015
Molica Stefano, Giannarelli Diana, Levato Luciano, Gentile Massimo, Mirabelli Rosanna, Morabito Fortunato
Abstract excerpt
BACKGROUND: We investigated the clinical relevance of classic and new prognostic markers, immunoglobulin heavy-chain variable (IGHV) gene mutational status, and chromosomal abnormalities in clinical monoclonal B lymphocytosis (cMBL) compared with chronic lymphocytic leukemia (CLL) Rai stage 0. PATIENTS AND METHODS: We analyzed the clinical outcomes in terms of the time to the first treatment (TTFT) of a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.